Vigil Neuroscience: Q4 Earnings Insights
Portfolio Pulse from Benzinga Insights
Vigil Neuroscience (NASDAQ:VIGL) reported Q4 earnings with an EPS of $-0.57, missing estimates by -8.0% and showing no revenue change from the previous year. The company had previously beaten EPS estimates last quarter but experienced a 4.0% share price drop the following day.
March 26, 2024 | 1:20 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Vigil Neuroscience reported a Q4 EPS of $-0.57, missing estimates by -8.0%, with no revenue change from last year. Previously, a beat in EPS estimates led to a 4.0% stock drop.
The missed earnings estimate and the historical context of a stock price drop following a previous earnings beat suggest a potential short-term negative impact on VIGL's stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100